Skip to main content

Main menu

  • Home
  • Issues
    • Issue in progress
    • Issues by date
  • Sections
    • Editorial
    • Review
    • Research
    • Commentary
    • Psychopharmacology for the Clinician
    • Letters to the Editor
  • Topic Collections
  • Instructions for Authors
    • Overview for authors
    • Submission checklist
    • Editorial policies
    • Publication fees
    • Submit a manuscript
    • Dr. Francis Wayne Quan Memorial Prize
    • Open access
  • Alerts
    • Email alerts
    • RSS
  • About
    • General information
    • Staff
    • Editorial Board
    • Contact
  • CMAJ JOURNALS
    • CMAJ
    • CMAJ Open
    • CJS
    • JAMC

User menu

Search

  • Advanced search
JPN
  • CMAJ JOURNALS
    • CMAJ
    • CMAJ Open
    • CJS
    • JAMC
JPN

Advanced Search

  • Home
  • Issues
    • Issue in progress
    • Issues by date
  • Sections
    • Editorial
    • Review
    • Research
    • Commentary
    • Psychopharmacology for the Clinician
    • Letters to the Editor
  • Topic Collections
  • Instructions for Authors
    • Overview for authors
    • Submission checklist
    • Editorial policies
    • Publication fees
    • Submit a manuscript
    • Dr. Francis Wayne Quan Memorial Prize
    • Open access
  • Alerts
    • Email alerts
    • RSS
  • About
    • General information
    • Staff
    • Editorial Board
    • Contact
  • Subscribe to our alerts
  • RSS feeds
  • Follow JPN on Twitter

More articles from commentary

  • You have access
    Effects of gut microbiota on the brain: implications for psychiatry
    Karen-Anne Neufeld and Jane A. Foster
    J Psychiatry Neurosci May 01, 2009 34 (3) 230-231;
  • You have access
    Glutamate and dopamine components in schizophrenia
    Philip Seeman
    J Psychiatry Neurosci March 01, 2009 34 (2) 143-149;
  • You have access
    A new wave in the genetics of psychiatric disorders: the copy number variant tsunami
    Ridha Joober and Patricia Boksa
    J Psychiatry Neurosci January 01, 2009 34 (1) 55-59;
  • You have access
    Ecological momentary assessment: what it is and why it is a method of the future in clinical psychopharmacology
    Debbie S. Moskowitz and Simon N. Young
    J Psychiatry Neurosci January 01, 2006 31 (1) 13-20;
  • You have access
    Glyceraldehyde-3-phosphate dehydrogenase as a target for small-molecule disease-modifying therapies in human neurodegenerative disorders
    Mark D. Berry
    J Psychiatry Neurosci September 01, 2004 29 (5) 337-345;
  • You have access
    Anterior cingulate dysfunction: Implications for psychiatric disorders?
    Murat Yücel, Stephen J. Wood, Alexander Fornito, Judith Riffkin, Dennis Velakoulis and Christos Pantelis
    J Psychiatry Neurosci September 01, 2003 28 (5) 350-354;
  • You have access
    The prodromal stage of psychotic illness: Observation, detection or intervention?
    Jean Addington
    J Psychiatry Neurosci March 01, 2003 28 (2) 93-97;
  • You have access
    Drug-metabolizing cytochrome P450s in the brain
    Sharon L. Miksys and Rachel F. Tyndale
    J Psychiatry Neurosci November 01, 2002 27 (6) 406-415;
  • You have access
    Evidence-based decisions about herbal products for treating mental disorders
    David M. Gardner
    J Psychiatry Neurosci September 01, 2002 27 (5) 324-333;
  • You have access
    Neuroactive steroids and anxiety disorders
    Jean-Michel Le Mellédo and Glen B. Baker
    J Psychiatry Neurosci May 01, 2002 27 (3) 161-165;

Pages

  • Previous
  • 1
  • 2

Content

  • Current issue
  • Past issues
  • Collections
  • Alerts
  • RSS

Authors & Reviewers

  • Overview for Authors
  • Submit a manuscript
  • Manuscript Submission Checklist

About

  • General Information
  • Staff
  • Editorial Board
  • Contact Us
  • Advertising
  • Reprints
  • Copyright and Permissions
  • Accessibility
  • CMA Civility Standards
CMAJ Group

Copyright 2023, CMA Impact Inc. or its licensors. All rights reserved. ISSN 1180-4882.

All editorial matter in JPN represents the opinions of the authors and not necessarily those of the Canadian Medical Association or its subsidiaries.
To receive any of these resources in an accessible format, please contact us at CMAJ Group, 500-1410 Blair Towers Place, Ottawa ON, K1J 9B9; p: 1-888-855-2555; e: [email protected].
View CMA's Accessibility policy.

Powered by HighWire